M
Mazowieckie Centrum Badan Klinicznych | Grodzisk Mazowiecki, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
RTX-GRT7039
Ocrelizumab
R935788
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple s...
Enrolling
Multiple Sclerosis, Primary Progressive
Drug: Ocrelizumab
Drug: Placebo
A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections...
Active, not recruiting
Osteoarthritis
Drug: Placebo
Drug: RTX-GRT7039
Trial sponsors
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems